Dana-Farber Cancer Institute: Carcinoma, Squamous Cell trials

The registry lists 14 Carcinoma, Squamous Cell studies with Dana-Farber Cancer Institute as lead sponsor. 1 are open to participants now and 8 have results posted.

Phase 1 6Phase 2 12No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Toripalimab With Chemotherapy for Sinus CancerRecruitingNCT06940180Phase 2
• Cemiplimab in AlloSCT/SOT Recipients With CSCCCompletedNCT04339062Phase 1/2Results posted
• Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHNActive, not recruitingNCT03341936Phase 2Results posted
• Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and NeckCompletedNCT02113878Phase 1Results posted
• Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma StudyTerminatedNCT01221753Phase 2Results posted
• A Pilot Study of Acupuncture Treatment for DysphagiaCompletedNCT00797732Not applicableResults posted
• Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and NeckTerminatedNCT00570674Phase 1/2Results posted
• Erlotinib in Women With Squamous Cell Carcinoma of the VulvarCompletedNCT00476476Phase 2Results posted
• Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and NeckCompletedNCT00459043Phase 2Results posted
• Stereotactic Boost for Oropharyngeal Squamous Cell CarcinomaWithdrawnNCT01586182Phase 1/2
• Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal CancerCompletedNCT00165490Phase 2
• Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00139269Phase 1/2
• Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and NeckCompletedNCT00139243Phase 1/2
• Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00139230Phase 2